The global market for Analgesic and Anti-inflammatory API was estimated to be worth US$ 702 million in 2023 and is forecast to a readjusted size of US$ 930.3 million by 2030 with a CAGR of 4.1% during the forecast period 2024-2030

Analgesic and Anti-inflammatory API - Market

Analgesics, also called painkillers, are medications that relieve different types of pain — from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Analgesic and Anti-inflammatory API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Analgesic and Anti-inflammatory API by region & country, by Type, and by Application.

The Analgesic and Anti-inflammatory API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Analgesic and Anti-inflammatory API.

Market Segmentation

Scope of Analgesic and Anti-inflammatory API - Market Report

Report Metric	Details
Report Name	Analgesic and Anti-inflammatory API - Market
Forecasted market size in 2030	US$ 930.3 million
CAGR	4.1%
Forecasted years	2024 - 2030
Segment by Type:	Ibuprofen Paracetamol Aspirin Naproxen Diclofenac Oxaprozin Dexibuprofen Others
Segment by Application	Adults Children
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	IOL, Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, BBCA Group, Hubei Biocause Group, Xinhua Pharm, Granules India Limited, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Hunan Zhongnan Pharmaceutical, Hebei Jingye Medical Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Analgesic and Anti-inflammatory API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Analgesic and Anti-inflammatory API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Analgesic and Anti-inflammatory API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Analgesic and Anti-inflammatory API - Market size in 2030?

Ans: The Analgesic and Anti-inflammatory API - Market size in 2030 will be US$ 930.3 million.

Who are the main players in the Analgesic and Anti-inflammatory API - Market report?

Ans: The main players in the Analgesic and Anti-inflammatory API - Market are IOL, Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, BBCA Group, Hubei Biocause Group, Xinhua Pharm, Granules India Limited, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Hunan Zhongnan Pharmaceutical, Hebei Jingye Medical Technology

What are the Application segmentation covered in the Analgesic and Anti-inflammatory API - Market report?

Ans: The Applications covered in the Analgesic and Anti-inflammatory API - Market report are Adults, Children

What are the Type segmentation covered in the Analgesic and Anti-inflammatory API - Market report?

Ans: The Types covered in the Analgesic and Anti-inflammatory API - Market report are Ibuprofen, Paracetamol, Aspirin, Naproxen, Diclofenac, Oxaprozin, Dexibuprofen, Others

1 Market Overview

1.1 Analgesic and Anti-inflammatory API Product Introduction

1.2 Global Analgesic and Anti-inflammatory API Market Size Forecast

1.2.1 Global Analgesic and Anti-inflammatory API Sales Value (2019-2030)

1.2.2 Global Analgesic and Anti-inflammatory API Sales Volume (2019-2030)

1.2.3 Global Analgesic and Anti-inflammatory API Sales Price (2019-2030)

1.3 Analgesic and Anti-inflammatory API Market Trends & Drivers

1.3.1 Analgesic and Anti-inflammatory API Industry Trends

1.3.2 Analgesic and Anti-inflammatory API Market Drivers & Opportunity

1.3.3 Analgesic and Anti-inflammatory API Market Challenges

1.3.4 Analgesic and Anti-inflammatory API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Analgesic and Anti-inflammatory API Players Revenue Ranking (2023)

2.2 Global Analgesic and Anti-inflammatory API Revenue by Company (2019-2024)

2.3 Global Analgesic and Anti-inflammatory API Players Sales Volume Ranking (2023)

2.4 Global Analgesic and Anti-inflammatory API Sales Volume by Company Players (2019-2024)

2.5 Global Analgesic and Anti-inflammatory API Average Price by Company (2019-2024)

2.6 Key Manufacturers Analgesic and Anti-inflammatory API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Analgesic and Anti-inflammatory API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Analgesic and Anti-inflammatory API

2.9 Analgesic and Anti-inflammatory API Market Competitive Analysis

2.9.1 Analgesic and Anti-inflammatory API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Analgesic and Anti-inflammatory API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Analgesic and Anti-inflammatory API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Ibuprofen

3.1.2 Paracetamol

3.1.3 Aspirin

3.1.4 Naproxen

3.1.5 Diclofenac

3.1.6 Oxaprozin

3.1.7 Dexibuprofen

3.1.8 Others

3.2 Global Analgesic and Anti-inflammatory API Sales Value by Type

3.2.1 Global Analgesic and Anti-inflammatory API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Analgesic and Anti-inflammatory API Sales Value, by Type (2019-2030)

3.2.3 Global Analgesic and Anti-inflammatory API Sales Value, by Type (%) (2019-2030)

3.3 Global Analgesic and Anti-inflammatory API Sales Volume by Type

3.3.1 Global Analgesic and Anti-inflammatory API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Analgesic and Anti-inflammatory API Sales Volume, by Type (2019-2030)

3.3.3 Global Analgesic and Anti-inflammatory API Sales Volume, by Type (%) (2019-2030)

3.4 Global Analgesic and Anti-inflammatory API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Adults

4.1.2 Children

4.2 Global Analgesic and Anti-inflammatory API Sales Value by Application

4.2.1 Global Analgesic and Anti-inflammatory API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Analgesic and Anti-inflammatory API Sales Value, by Application (2019-2030)

4.2.3 Global Analgesic and Anti-inflammatory API Sales Value, by Application (%) (2019-2030)

4.3 Global Analgesic and Anti-inflammatory API Sales Volume by Application

4.3.1 Global Analgesic and Anti-inflammatory API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Analgesic and Anti-inflammatory API Sales Volume, by Application (2019-2030)

4.3.3 Global Analgesic and Anti-inflammatory API Sales Volume, by Application (%) (2019-2030)

4.4 Global Analgesic and Anti-inflammatory API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Analgesic and Anti-inflammatory API Sales Value by Region

5.1.1 Global Analgesic and Anti-inflammatory API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Analgesic and Anti-inflammatory API Sales Value by Region (2019-2024)

5.1.3 Global Analgesic and Anti-inflammatory API Sales Value by Region (2025-2030)

5.1.4 Global Analgesic and Anti-inflammatory API Sales Value by Region (%), (2019-2030)

5.2 Global Analgesic and Anti-inflammatory API Sales Volume by Region

5.2.1 Global Analgesic and Anti-inflammatory API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Analgesic and Anti-inflammatory API Sales Volume by Region (2019-2024)

5.2.3 Global Analgesic and Anti-inflammatory API Sales Volume by Region (2025-2030)

5.2.4 Global Analgesic and Anti-inflammatory API Sales Volume by Region (%), (2019-2030)

5.3 Global Analgesic and Anti-inflammatory API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Analgesic and Anti-inflammatory API Sales Value, 2019-2030

5.4.2 North America Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Analgesic and Anti-inflammatory API Sales Value, 2019-2030

5.5.2 Europe Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Analgesic and Anti-inflammatory API Sales Value, 2019-2030

5.6.2 Asia Pacific Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Analgesic and Anti-inflammatory API Sales Value, 2019-2030

5.7.2 South America Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales Value, 2019-2030

5.8.2 Middle East & Africa Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Analgesic and Anti-inflammatory API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Analgesic and Anti-inflammatory API Sales Value

6.2.1 Key Countries/Regions Analgesic and Anti-inflammatory API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Analgesic and Anti-inflammatory API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Analgesic and Anti-inflammatory API Sales Value, 2019-2030

6.3.2 United States Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Analgesic and Anti-inflammatory API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Analgesic and Anti-inflammatory API Sales Value, 2019-2030

6.4.2 Europe Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Analgesic and Anti-inflammatory API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Analgesic and Anti-inflammatory API Sales Value, 2019-2030

6.5.2 China Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Analgesic and Anti-inflammatory API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Analgesic and Anti-inflammatory API Sales Value, 2019-2030

6.6.2 Japan Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Analgesic and Anti-inflammatory API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Analgesic and Anti-inflammatory API Sales Value, 2019-2030

6.7.2 South Korea Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Analgesic and Anti-inflammatory API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Analgesic and Anti-inflammatory API Sales Value, 2019-2030

6.8.2 Southeast Asia Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Analgesic and Anti-inflammatory API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Analgesic and Anti-inflammatory API Sales Value, 2019-2030

6.9.2 India Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Analgesic and Anti-inflammatory API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 IOL

7.1.1 IOL Company Information

7.1.2 IOL Introduction and Business Overview

7.1.3 IOL Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 IOL Analgesic and Anti-inflammatory API Product Offerings

7.1.5 IOL Recent Development

7.2 Mallinckrodt Pharmaceuticals

7.2.1 Mallinckrodt Pharmaceuticals Company Information

7.2.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview

7.2.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Offerings

7.2.5 Mallinckrodt Pharmaceuticals Recent Development

7.3 Anqiu Lu'an Pharmaceutical

7.3.1 Anqiu Lu'an Pharmaceutical Company Information

7.3.2 Anqiu Lu'an Pharmaceutical Introduction and Business Overview

7.3.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Offerings

7.3.5 Anqiu Lu'an Pharmaceutical Recent Development

7.4 Novacyl

7.4.1 Novacyl Company Information

7.4.2 Novacyl Introduction and Business Overview

7.4.3 Novacyl Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Novacyl Analgesic and Anti-inflammatory API Product Offerings

7.4.5 Novacyl Recent Development

7.5 BASF

7.5.1 BASF Company Information

7.5.2 BASF Introduction and Business Overview

7.5.3 BASF Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.5.4 BASF Analgesic and Anti-inflammatory API Product Offerings

7.5.5 BASF Recent Development

7.6 BBCA Group

7.6.1 BBCA Group Company Information

7.6.2 BBCA Group Introduction and Business Overview

7.6.3 BBCA Group Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.6.4 BBCA Group Analgesic and Anti-inflammatory API Product Offerings

7.6.5 BBCA Group Recent Development

7.7 Hubei Biocause Group

7.7.1 Hubei Biocause Group Company Information

7.7.2 Hubei Biocause Group Introduction and Business Overview

7.7.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Hubei Biocause Group Analgesic and Anti-inflammatory API Product Offerings

7.7.5 Hubei Biocause Group Recent Development

7.8 Xinhua Pharm

7.8.1 Xinhua Pharm Company Information

7.8.2 Xinhua Pharm Introduction and Business Overview

7.8.3 Xinhua Pharm Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Xinhua Pharm Analgesic and Anti-inflammatory API Product Offerings

7.8.5 Xinhua Pharm Recent Development

7.9 Granules India Limited

7.9.1 Granules India Limited Company Information

7.9.2 Granules India Limited Introduction and Business Overview

7.9.3 Granules India Limited Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Granules India Limited Analgesic and Anti-inflammatory API Product Offerings

7.9.5 Granules India Limited Recent Development

7.10 Hebei Jiheng Pharmaceutical

7.10.1 Hebei Jiheng Pharmaceutical Company Information

7.10.2 Hebei Jiheng Pharmaceutical Introduction and Business Overview

7.10.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Offerings

7.10.5 Hebei Jiheng Pharmaceutical Recent Development

7.11 Zhejiang Kangle Pharmaceutical

7.11.1 Zhejiang Kangle Pharmaceutical Company Information

7.11.2 Zhejiang Kangle Pharmaceutical Introduction and Business Overview

7.11.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Offerings

7.11.5 Zhejiang Kangle Pharmaceutical Recent Development

7.12 Hunan Zhongnan Pharmaceutical

7.12.1 Hunan Zhongnan Pharmaceutical Company Information

7.12.2 Hunan Zhongnan Pharmaceutical Introduction and Business Overview

7.12.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Offerings

7.12.5 Hunan Zhongnan Pharmaceutical Recent Development

7.13 Hebei Jingye Medical Technology

7.13.1 Hebei Jingye Medical Technology Company Information

7.13.2 Hebei Jingye Medical Technology Introduction and Business Overview

7.13.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Offerings

7.13.5 Hebei Jingye Medical Technology Recent Development

8 Industry Chain Analysis

8.1 Analgesic and Anti-inflammatory API Industrial Chain

8.2 Analgesic and Anti-inflammatory API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Analgesic and Anti-inflammatory API Sales Model

8.5.2 Sales Channel

8.5.3 Analgesic and Anti-inflammatory API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

IOL

Mallinckrodt Pharmaceuticals

Anqiu Lu’an Pharmaceutical

Granules India Limited

Hebei Jiheng Pharmaceutical

Zhejiang Kangle Pharmaceutical

Hunan Zhongnan Pharmaceutical

Hebei Jingye Medical Technology

List of Tables

Table 1. Analgesic and Anti-inflammatory API Market Trends

Table 2. Analgesic and Anti-inflammatory API Market Drivers & Opportunity

Table 3. Analgesic and Anti-inflammatory API Market Challenges

Table 4. Analgesic and Anti-inflammatory API Market Restraints

Table 5. Global Analgesic and Anti-inflammatory API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Analgesic and Anti-inflammatory API Revenue Market Share by Company (2019-2024)

Table 7. Global Analgesic and Anti-inflammatory API Sales Volume by Company (2019-2024) & (Tons)

Table 8. Global Analgesic and Anti-inflammatory API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Analgesic and Anti-inflammatory API Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Analgesic and Anti-inflammatory API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Analgesic and Anti-inflammatory API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Analgesic and Anti-inflammatory API

Table 13. Global Analgesic and Anti-inflammatory API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Analgesic and Anti-inflammatory API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Analgesic and Anti-inflammatory API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Analgesic and Anti-inflammatory API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Analgesic and Anti-inflammatory API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Analgesic and Anti-inflammatory API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Analgesic and Anti-inflammatory API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Analgesic and Anti-inflammatory API Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)

Table 22. Global Analgesic and Anti-inflammatory API Sales Volume by Type (2019-2024) & (Tons)

Table 23. Global Analgesic and Anti-inflammatory API Sales Volume by Type (2025-2030) & (Tons)

Table 24. Global Analgesic and Anti-inflammatory API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Analgesic and Anti-inflammatory API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Analgesic and Anti-inflammatory API Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Analgesic and Anti-inflammatory API Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Analgesic and Anti-inflammatory API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Analgesic and Anti-inflammatory API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Analgesic and Anti-inflammatory API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Analgesic and Anti-inflammatory API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Analgesic and Anti-inflammatory API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Analgesic and Anti-inflammatory API Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)

Table 34. Global Analgesic and Anti-inflammatory API Sales Volume by Application (2019-2024) & (Tons)

Table 35. Global Analgesic and Anti-inflammatory API Sales Volume by Application (2025-2030) & (Tons)

Table 36. Global Analgesic and Anti-inflammatory API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Analgesic and Anti-inflammatory API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Analgesic and Anti-inflammatory API Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Analgesic and Anti-inflammatory API Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Analgesic and Anti-inflammatory API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Analgesic and Anti-inflammatory API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Analgesic and Anti-inflammatory API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Analgesic and Anti-inflammatory API Sales Value by Region (2019-2024) & (%)

Table 44. Global Analgesic and Anti-inflammatory API Sales Value by Region (2025-2030) & (%)

Table 45. Global Analgesic and Anti-inflammatory API Sales Volume by Region (Tons): 2019 VS 2023 VS 2030

Table 46. Global Analgesic and Anti-inflammatory API Sales Volume by Region (2019-2024) & (Tons)

Table 47. Global Analgesic and Anti-inflammatory API Sales Volume by Region (2025-2030) & (Tons)

Table 48. Global Analgesic and Anti-inflammatory API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Analgesic and Anti-inflammatory API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Analgesic and Anti-inflammatory API Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Analgesic and Anti-inflammatory API Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Analgesic and Anti-inflammatory API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Analgesic and Anti-inflammatory API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Analgesic and Anti-inflammatory API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Analgesic and Anti-inflammatory API Sales Volume, (2019-2024) & (Tons)

Table 56. Key Countries/Regions Analgesic and Anti-inflammatory API Sales Volume, (2025-2030) & (Tons)

Table 57. IOL Company Information

Table 58. IOL Introduction and Business Overview

Table 59. IOL Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. IOL Analgesic and Anti-inflammatory API Product Offerings

Table 61. IOL Recent Development

Table 62. Mallinckrodt Pharmaceuticals Company Information

Table 63. Mallinckrodt Pharmaceuticals Introduction and Business Overview

Table 64. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Offerings

Table 66. Mallinckrodt Pharmaceuticals Recent Development

Table 67. Anqiu Lu'an Pharmaceutical Company Information

Table 68. Anqiu Lu'an Pharmaceutical Introduction and Business Overview

Table 69. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Offerings

Table 71. Anqiu Lu'an Pharmaceutical Recent Development

Table 72. Novacyl Company Information

Table 73. Novacyl Introduction and Business Overview

Table 74. Novacyl Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Novacyl Analgesic and Anti-inflammatory API Product Offerings

Table 76. Novacyl Recent Development

Table 77. BASF Company Information

Table 78. BASF Introduction and Business Overview

Table 79. BASF Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. BASF Analgesic and Anti-inflammatory API Product Offerings

Table 81. BASF Recent Development

Table 82. BBCA Group Company Information

Table 83. BBCA Group Introduction and Business Overview

Table 84. BBCA Group Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. BBCA Group Analgesic and Anti-inflammatory API Product Offerings

Table 86. BBCA Group Recent Development

Table 87. Hubei Biocause Group Company Information

Table 88. Hubei Biocause Group Introduction and Business Overview

Table 89. Hubei Biocause Group Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. Hubei Biocause Group Analgesic and Anti-inflammatory API Product Offerings

Table 91. Hubei Biocause Group Recent Development

Table 92. Xinhua Pharm Company Information

Table 93. Xinhua Pharm Introduction and Business Overview

Table 94. Xinhua Pharm Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. Xinhua Pharm Analgesic and Anti-inflammatory API Product Offerings

Table 96. Xinhua Pharm Recent Development

Table 97. Granules India Limited Company Information

Table 98. Granules India Limited Introduction and Business Overview

Table 99. Granules India Limited Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. Granules India Limited Analgesic and Anti-inflammatory API Product Offerings

Table 101. Granules India Limited Recent Development

Table 102. Hebei Jiheng Pharmaceutical Company Information

Table 103. Hebei Jiheng Pharmaceutical Introduction and Business Overview

Table 104. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 105. Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Offerings

Table 106. Hebei Jiheng Pharmaceutical Recent Development

Table 107. Zhejiang Kangle Pharmaceutical Company Information

Table 108. Zhejiang Kangle Pharmaceutical Introduction and Business Overview

Table 109. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 110. Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Offerings

Table 111. Zhejiang Kangle Pharmaceutical Recent Development

Table 112. Hunan Zhongnan Pharmaceutical Company Information

Table 113. Hunan Zhongnan Pharmaceutical Introduction and Business Overview

Table 114. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 115. Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Offerings

Table 116. Hunan Zhongnan Pharmaceutical Recent Development

Table 117. Hebei Jingye Medical Technology Company Information

Table 118. Hebei Jingye Medical Technology Introduction and Business Overview

Table 119. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 120. Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Offerings

Table 121. Hebei Jingye Medical Technology Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Analgesic and Anti-inflammatory API Downstream Customers

Table 125. Analgesic and Anti-inflammatory API Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Analgesic and Anti-inflammatory API Product Picture

Figure 2. Global Analgesic and Anti-inflammatory API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Analgesic and Anti-inflammatory API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Analgesic and Anti-inflammatory API Sales Volume (2019-2030) & (Tons)

Figure 5. Global Analgesic and Anti-inflammatory API Sales Price (2019-2030) & (US$/Ton)

Figure 6. Analgesic and Anti-inflammatory API Report Years Considered

Figure 7. Global Analgesic and Anti-inflammatory API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Analgesic and Anti-inflammatory API Players Sales Volume Ranking (2023) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Analgesic and Anti-inflammatory API Revenue in 2023

Figure 10. Analgesic and Anti-inflammatory API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Ibuprofen Picture

Figure 12. Paracetamol Picture

Figure 13. Aspirin Picture

Figure 14. Naproxen Picture

Figure 15. Diclofenac Picture

Figure 16. Oxaprozin Picture

Figure 17. Dexibuprofen Picture

Figure 18. Others Picture

Figure 19. Global Analgesic and Anti-inflammatory API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 20. Global Analgesic and Anti-inflammatory API Sales Value Market Share by Type, 2023 & 2030

Figure 21. Global Analgesic and Anti-inflammatory API Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)

Figure 22. Global Analgesic and Anti-inflammatory API Sales Volume Market Share by Type, 2023 & 2030

Figure 23. Global Analgesic and Anti-inflammatory API Price by Type (2019-2030) & (US$/Ton)

Figure 24. Product Picture of Adults

Figure 25. Product Picture of Children

Figure 26. Global Analgesic and Anti-inflammatory API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Analgesic and Anti-inflammatory API Sales Value Market Share by Application, 2023 & 2030

Figure 28. Global Analgesic and Anti-inflammatory API Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)

Figure 29. Global Analgesic and Anti-inflammatory API Sales Volume Market Share by Application, 2023 & 2030

Figure 30. Global Analgesic and Anti-inflammatory API Price by Application (2019-2030) & (US$/Ton)

Figure 31. North America Analgesic and Anti-inflammatory API Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Analgesic and Anti-inflammatory API Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Analgesic and Anti-inflammatory API Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Analgesic and Anti-inflammatory API Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Analgesic and Anti-inflammatory API Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Analgesic and Anti-inflammatory API Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Analgesic and Anti-inflammatory API Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Analgesic and Anti-inflammatory API Sales Volume (%), (2019-2030)

Figure 43. United States Analgesic and Anti-inflammatory API Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Analgesic and Anti-inflammatory API Sales Value by Application (%), 2023 VS 2030

Figure 46. Europe Analgesic and Anti-inflammatory API Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Analgesic and Anti-inflammatory API Sales Value by Application (%), 2023 VS 2030

Figure 49. China Analgesic and Anti-inflammatory API Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

Figure 51. China Analgesic and Anti-inflammatory API Sales Value by Application (%), 2023 VS 2030

Figure 52. Japan Analgesic and Anti-inflammatory API Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Analgesic and Anti-inflammatory API Sales Value by Application (%), 2023 VS 2030

Figure 55. South Korea Analgesic and Anti-inflammatory API Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Analgesic and Anti-inflammatory API Sales Value by Application (%), 2023 VS 2030

Figure 58. Southeast Asia Analgesic and Anti-inflammatory API Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Analgesic and Anti-inflammatory API Sales Value by Application (%), 2023 VS 2030

Figure 61. India Analgesic and Anti-inflammatory API Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Analgesic and Anti-inflammatory API Sales Value by Type (%), 2023 VS 2030

Figure 63. India Analgesic and Anti-inflammatory API Sales Value by Application (%), 2023 VS 2030

Figure 64. Analgesic and Anti-inflammatory API Industrial Chain

Figure 65. Analgesic and Anti-inflammatory API Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions